Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Sarepta Therapeutics,, Inc. Common Stock | SRPT

Daily Technical Analysis of Sarepta Therapeutics,, Inc. Common Stock

Sarepta Therapeutics hasn't moved too much today but is slightly down, it has lost -0.74% since yesterday. It looks like SRPT may be interacting with an upward sloping support line. These can create nice entry points since it can have both momentum and support. SRPT hasn't established a very clear directional momentum over the last few months. So it's not clear if it has the energy to break through or not.

If we get a reversal off of support and Sarepta Therapeutics starts moving up, it can probably get to $157.19 at which point it'll need to break through that resistance level in order to keep moving higher. There aren't very obvious support levels beneath this point. So put those stop losses on, this thing has room to fall if buyers don't come in at this level.


Analyst Ratings for Sarepta Therapeutics By Price Target And Rating

The analysts feel pretty optimistic about Sarepta Therapeutics and have been assigning positive ratings. The current Analysts Sentiment Score is 249.30. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. Oppenheimer announced a lowering of their price target to $150.00 from $180.00 on 2023-03-09. JPMorgan Chase & Co. provided a price target boost of 34.64% to $206.00 from $153.00 on 2023-03-03. On 2023-03-01 Barclays increased their price target by 14.09% to $170.00. On 2023-03-01 Morgan Stanley upgraded Sarepta Therapeutics from Equal Weight to Overweight and moved up their price target to $187.00 which is a 32.62% increase. On 2023-03-01 The Goldman Sachs Group increased their price target by 11.11% to $190.00. On 2023-03-01 Credit Suisse Group increased their price target by 5.11% to $144.00. Robert W. Baird provided a price target boost of 32.89% to $202.00 from $152.00 on 2023-03-01. Royal Bank of Canada gave a boost to their price target and moved to $226.00 from $195.00 on 2023-03-01. Needham & Company LLC boosted their price targ by 25% to $200.00 on 2023-03-01. On 2023-01-20 there was confirmation of the previous rating by SVB Leerink which was Outperform and they set their price target at $160.00.

Company Ratings Score ?
Composite analyst sentiment score
Positive Ratings Negative Ratings Boost Price Target Lower Price Target
SRPT249.30160.43-0.45367.18-28.57

Earnings Per Share (EPS) Estimates By Year and Quarter

(updated 2022-11-28)
Company YOY Growth Score (typical -20 to +20) Revision Directions (-6 to +6)
SRPT-5.33-5.20

Short interest for Sarepta Therapeutics

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Company Short Score (typical 1-15) ?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
Short Interest Days to Cover Rate of Change Shares Short
SRPT7.51%7.935237.5-4.626910000

How Sarepta Therapeutics compares to the broader Healthcare sector and the more specific Biotechnology industry

Segment Count 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Analysts Ratings ?
Biotechnology

Show Me Companies With:

S-Momentum: Highest | Lowest
1 Day Growth: Highest | Lowest
5 Day Growth: Highest | Lowest
1 Month Growth: Highest | Lowest
6 Month Growth: Highest | Lowest
354-0.271.802.8413.3413.8815.8158.77-14.14-10.57-9.88-28374.34-6755.493.673.886.6351.67
Healthcare

Show Me Companies With:

S-Momentum: Highest | Lowest
1 Day Growth: Highest | Lowest
5 Day Growth: Highest | Lowest
1 Month Growth: Highest | Lowest
6 Month Growth: Highest | Lowest
593-0.111.531.379.769.846.2758.86-14.04-10.26-11.36-26226.85-6830.393.924.435.9838.86

Social Sentiment for Sarepta Therapeutics

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.

Ticker Social Sentiment(1-10)
SRPT8.00

Companies with the highest correlation to Sarepta Therapeutics

Company Score 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Score
SGMO | Sangamo Therapeutics, Inc0.89-2.3113.910.00-41.20-62.76-70.2660-100.48-116.44-158.01-57224.06-1568.13008.30077
INSM | Insmed, Inc.0.71.492.745.9412.346.051.1372-4.56-7.55-7.30-4906.69-5808.14008.2465
IOVA | Iovance Biotherapeutics, 0.68-3.03-9.206.5317.1610.13-12.58415.217.456.45-13018.65-3854.94009.55114
CDLX | Cardlytics, Inc. Common S0.681.32-6.13-10.0758.1128.85-81.5045-15.44-29.55-12.80-63679.55-2770.99008.41537
RARE | Ultragenyx Pharmaceutical0.67-0.461.449.4926.6430.55-5.177612.3113.7510.57-800.17-11353.77005.25037
MTLS | Materialise NV0.65-1.52-3.8515.0127.697.16-33.99632.75-2.62-9.61-1236.49-3571.13002.22986
UBER | Uber Technologies, Inc.0.653.324.543.8924.7952.5955.966643.4155.0960.71-212.95-30075.50001.18638

Top 3 correlating companies

See full charts for all peers

Sentiment Score

How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.

Earnings Estimates
Analyst Rating
Price Targets
Short Interest
Financials
Options Sentiment
Institutional Ownership
Social Sentiment
Fidelity Summary
Overall Summary Notes
Calculated Sentiment Sum

Score Sum
(1-45)

/

Average
(1-5)

+

Pattern Rank
(1-5)

=

Total Score
(1-10)

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-